• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

保留肾单位手术治疗多灶性和遗传性肾肿瘤。

Nephron-sparing surgery for multifocal and hereditary renal tumors.

作者信息

Metwalli Adam R, Linehan William M

机构信息

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

出版信息

Curr Opin Urol. 2014 Sep;24(5):466-73. doi: 10.1097/MOU.0000000000000094.

DOI:10.1097/MOU.0000000000000094
PMID:25014245
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4441729/
Abstract

PURPOSE OF REVIEW

Despite the controversy surrounding the benefits of nephron-sparing surgery, multiple absolute indications for nephron-sparing surgery still exist, including the classic indications of hereditary and bilateral kidney tumors.

RECENT FINDINGS

Multiple genetic mutations have been identified which lead to hereditary kidney cancer conditions. These are briefly reviewed because the surgical management of hereditary kidney tumors depends on the genetic and histologic subtypes involved. Clear understanding of these hereditary conditions is crucial for proper surgical management of these tumors.

SUMMARY

Complex partial nephrectomy for multiple renal tumors, or multiplex partial nephrectomy, requires not only exceptional surgical skills but expertise of numerous nonsurgical methodologies, such as hands-on intraoperative ultrasonography and interpretation of multiple imaging modalities. In addition, multidisciplinary management is crucial for optimal outcomes in patient care. This review evaluates the most advanced surgical techniques and perioperative management required to successfully care for these challenging cases.

摘要

综述目的

尽管围绕保留肾单位手术的益处存在争议,但保留肾单位手术仍有多个绝对适应证,包括遗传性和双侧肾肿瘤的经典适应证。

最新发现

已鉴定出多种导致遗传性肾癌的基因突变。由于遗传性肾肿瘤的手术管理取决于所涉及的基因和组织学亚型,因此对这些突变进行简要综述。清楚了解这些遗传性疾病对于这些肿瘤的正确手术管理至关重要。

总结

对于多发肾肿瘤进行复杂的部分肾切除术,即多重部分肾切除术,不仅需要卓越的手术技能,还需要多种非手术方法的专业知识,如术中亲手操作超声检查以及解读多种影像学检查结果。此外,多学科管理对于患者护理的最佳结果至关重要。本综述评估了成功处理这些具有挑战性病例所需的最先进手术技术和围手术期管理。

相似文献

1
Nephron-sparing surgery for multifocal and hereditary renal tumors.保留肾单位手术治疗多灶性和遗传性肾肿瘤。
Curr Opin Urol. 2014 Sep;24(5):466-73. doi: 10.1097/MOU.0000000000000094.
2
Precision Surgery and Kidney Cancer: Knowledge of Genetic Alterations Influences Surgical Management.精准外科与肾癌:基因改变知识影响手术治疗。
Genes (Basel). 2021 Feb 11;12(2):261. doi: 10.3390/genes12020261.
3
Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience.遗传性肾细胞癌患者的保留肾实质手术:10年经验
J Urol. 2001 Mar;165(3):777-81.
4
Oncological outcomes of partial nephrectomy for multifocal renal cell carcinoma greater than 4 cm.多灶性大于 4cm 肾细胞癌行部分肾切除术的肿瘤学结果。
J Urol. 2010 Jul;184(1):59-63. doi: 10.1016/j.juro.2010.03.035. Epub 2010 May 15.
5
[Renal cell carcinoma in von Hippel-Lindau disease. Nephron sparing surgery.].[冯·希佩尔-林道病中的肾细胞癌。保留肾单位手术。]
Arch Esp Urol. 2018 Nov;71(9):757-764.
6
Nephron sparing surgery for renal cell carcinoma and von Hippel-Lindau's disease: a single center experience.肾细胞癌和冯·希佩尔-林道病的保留肾单位手术:单中心经验
J Urol. 2003 Nov;170(5):1752-5. doi: 10.1097/01.ju.0000092780.85876.de.
7
Kidney autotransplantation after nephrectomy and work bench surgery as an ultimate approach to nephron-sparing surgery.肾切除术后肾自体移植和工作檯手术作为保肾手术的终极方法。
World J Surg Oncol. 2018 Feb 20;16(1):35. doi: 10.1186/s12957-018-1338-1.
8
Choice of operation for clinically localized renal tumor.临床局限性肾肿瘤的手术选择
Urol Clin North Am. 2008 Nov;35(4):645-55; vii. doi: 10.1016/j.ucl.2008.07.002.
9
Outcomes of partial nephrectomy for clinical T1b and T2 renal tumors.临床T1b和T2期肾肿瘤行部分肾切除术的结果。
Curr Opin Urol. 2014 Sep;24(5):448-52. doi: 10.1097/MOU.0000000000000081.
10
Genetics of familial renal cancers.家族性肾细胞癌的遗传学。
Nephron Exp Nephrol. 2011;118(1):e21-6. doi: 10.1159/000320892. Epub 2010 Nov 11.

引用本文的文献

1
Clinical, Pathologic, and Genetic Correlates of Nuclear Grade in von Hippel-Lindau-associated Renal Cell Carcinoma.冯·希佩尔-林道综合征相关肾细胞癌核分级的临床、病理及遗传学相关性
Urology. 2025 Jul 23. doi: 10.1016/j.urology.2025.07.031.
2
Understanding the Metabolic Effects of Surgically Induced Renal Ischemia in Humans: A Temporal Approach.了解手术诱导的人类肾缺血的代谢效应:一种时间性方法。
Metabolites. 2025 Jul 8;15(7):462. doi: 10.3390/metabo15070462.
3
Feasibility and perioperative outcomes of re-operative retroperitoneal robotic partial nephrectomy.再次手术的腹膜后机器人辅助肾部分切除术的可行性及围手术期结果
Urol Oncol. 2025 Sep;43(9):525.e1-525.e8. doi: 10.1016/j.urolonc.2025.05.003. Epub 2025 May 27.
4
Repeat robotic nephron-sparing surgery for metachronous multifocal tumors in a solitary kidney: a case report.孤立肾中异时性多灶性肿瘤的重复机器人保留肾单位手术:病例报告
J Med Life. 2025 Apr;18(4):393-396. doi: 10.25122/jml-2025-0059.
5
A Decade of Surgical Management of Renal Cell Carcinoma with IVC Thrombus and Bilateral Renal Tumors: Emphasis on Auto-transplantation.肾细胞癌伴下腔静脉血栓形成和双侧肾肿瘤的手术治疗十年:重点关注自体肾移植
J Kidney Cancer VHL. 2025 Apr 24;12(2):19-26. doi: 10.15586/jkc.v12i2.367. eCollection 2025.
6
Urinary leak after partial nephrectomy: Insights from a cohort with hereditary, multifocal, and reoperative cases.肾部分切除术后尿漏:来自遗传性、多灶性和再次手术病例队列的见解
Urol Oncol. 2025 Aug;43(8):470.e11-470.e18. doi: 10.1016/j.urolonc.2025.03.013. Epub 2025 Apr 2.
7
Cumulative Impact of Serial Partial Nephrectomy for the Treatment of Recurrent Renal Masses.连续部分肾切除术治疗复发性肾肿瘤的累积影响。
J Urol. 2024 Sep;212(3):431-440. doi: 10.1097/JU.0000000000004099. Epub 2024 Jun 12.
8
Sporadic Renal Hemangioblastoma: A Case Report of a Rare Entity.散发性肾血管母细胞瘤:一例罕见病例报告
Cureus. 2023 Oct 16;15(10):e47102. doi: 10.7759/cureus.47102. eCollection 2023 Oct.
9
A novel multiplex score to predict outcomes of partial nephrectomy for multiple tumors.一种用于预测多肿瘤部分肾切除术结局的新型多重评分。
Urol Oncol. 2023 May;41(5):257.e1-257.e6. doi: 10.1016/j.urolonc.2023.03.007. Epub 2023 Apr 8.
10
A diagnosis of Birt-Hogg-Dubé syndrome in individuals with Smith-Magenis syndrome: Recommendation for cancer screening.诊断史密斯-马根尼斯综合征患者存在伯特-霍格-杜布综合征:癌症筛查建议。
Am J Med Genet A. 2023 Feb;191(2):490-497. doi: 10.1002/ajmg.a.63049. Epub 2022 Dec 13.

本文引用的文献

1
Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management.定义早发性肾癌:对种系和体细胞突变检测及临床管理的影响。
J Clin Oncol. 2014 Feb 10;32(5):431-7. doi: 10.1200/JCO.2013.50.8192. Epub 2013 Dec 30.
2
Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases.拓展遗传性 BAP1 癌症易感性综合征的临床表型,报告三例新病例。
Genes Chromosomes Cancer. 2014 Feb;53(2):177-82. doi: 10.1002/gcc.22129. Epub 2013 Nov 15.
3
Parenchymal volume preservation and ischemia during partial nephrectomy: functional and volumetric analysis.部分肾切除术期间的实质体积保存和缺血:功能和容积分析。
Urology. 2013 Aug;82(2):263-8. doi: 10.1016/j.urology.2013.03.068. Epub 2013 Jun 20.
4
Germline PTEN mutation Cowden syndrome: an underappreciated form of hereditary kidney cancer.胚系 PTEN 突变型 Cowden 综合征:一种被低估的遗传性肾癌形式。
J Urol. 2013 Dec;190(6):1990-8. doi: 10.1016/j.juro.2013.06.012. Epub 2013 Jun 11.
5
A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinoma.一种新的胚系 BAP1 突变可导致家族性透明细胞肾细胞癌。
Mol Cancer Res. 2013 Sep;11(9):1061-1071. doi: 10.1158/1541-7786.MCR-13-0111. Epub 2013 May 24.
6
Germline BAP1 mutations predispose to renal cell carcinomas.胚系 BAP1 突变易导致肾细胞癌。
Am J Hum Genet. 2013 Jun 6;92(6):974-80. doi: 10.1016/j.ajhg.2013.04.012. Epub 2013 May 16.
7
Tolerance of the human kidney to isolated controlled ischemia.人类肾脏对孤立性控制性缺血的耐受能力。
J Am Soc Nephrol. 2013 Feb;24(3):506-17. doi: 10.1681/ASN.2012080786. Epub 2013 Feb 14.
8
Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer.琥珀酸脱氢酶肾细胞癌:癌症中沃伯格效应的一个侵袭性范例。
J Urol. 2012 Dec;188(6):2063-71. doi: 10.1016/j.juro.2012.08.030. Epub 2012 Oct 18.
9
Outcomes of patients with surgically treated bilateral renal masses and a minimum of 10 years of followup.手术治疗双侧肾脏肿块且随访时间至少 10 年的患者的结果。
J Urol. 2012 Dec;188(6):2084-8. doi: 10.1016/j.juro.2012.08.038. Epub 2012 Oct 18.
10
Positive surgical margins after nephron-sparing surgery for renal cell carcinoma: incidence, clinical impact, and management.肾细胞癌保肾手术后的阳性切缘:发生率、临床影响和处理。
Clin Genitourin Cancer. 2013 Mar;11(1):5-9. doi: 10.1016/j.clgc.2012.09.010. Epub 2012 Oct 17.